Actively Recruiting
PET Imaging to Study Brain Inflammation in Adults Aged 18 to 65 With Neurological Symptoms After COVID-19 Infection Compared to Healthy Volunteers
Led by University of Alabama at Birmingham · Updated on 2026-08-12
60
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating neuroinflammation in individuals with post-acute sequelae of SARS-CoV-2 PASC using a special imaging agent called Fluorodeoxyglucose18F-labeled DPA-714. This study compares brain inflammation in people with neurological symptoms after COVID-19 infection to healthy volunteers. The goal is to visualize and measure brain inflammation related to PASC, which can cause long-lasting neurological problems. Participants receive a PETMRI scan using the DPA-714 tracer, which binds to a brain protein linked to inflammation. Both PASC patients and healthy volunteers are included. The study involves a single group assignment without randomization or masking. Participants will be genotyped to confirm the affinity of the tracer binding and must meet specific health and neurological criteria. The imaging is done once, followed by clinical follow-up usually within six weeks. During the study, participants undergo brain imaging and clinical evaluations. Researchers measure regional brain TSPO levels, which indicate inflammation, using PET scans. The study monitors participants from the injection and scan date through clinical follow-up. Safety is considered by excluding participants with certain medical conditions or who cannot undergo MRI. The entire participation period lasts until clinical follow-up is complete, typically within six weeks after scanning.
CONDITIONS
Brief Title
Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2) Infection
Research Team
A
April Riddle
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here